Cargando…
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
INTRODUCTION: Advanced liver disease with massive liver damage may affect the metabolism of hypoglycemic agents and increase the risk of hypoglycemia. We conduct this research to compare the risk of severe hypoglycemia between patients with type 2 diabetes, with and without compensated liver cirrhos...
Autores principales: | Yen, Fu-Shun, Hou, Ming-Chih, Liu, Jia-Sin, Hsu, Chih-Cheng, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845885/ https://www.ncbi.nlm.nih.gov/pubmed/36687427 http://dx.doi.org/10.3389/fmed.2022.962337 |
Ejemplares similares
-
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021) -
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020) -
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)